Table 2.

Laboratory and echocardiographic parameters of study population.

Variable	Nonrecurrent group (n=193)	Recurrent group (n=70)	P value
Glucose(mmol/L)	5.11 (4.61, 5.61)	5.06 (4.65, 5.79)	0.862
Scr(umol/L)	72.67±17.12	73.52±17.60	0.724
UA (umol/L)	348.79±84.50	354.29±92.49	0.649
TC (mmol/L)	4.34 (3.86, 5.10)	4.21 (3.55, 4.67)	0.027*
LDL-C(mmol/L)	2.48 (2.06, 3.14)	2.31 (1.87, 2.71)	0.046*
HDL-C(mmol/L)	1.15 (0.99, 1.36)	1.10 (0.94, 1.27)	0.096
TG (mmol/L)	1.47 (1.06, 2.04)	1.46 (1.01, 2.16)	0.673
Lymphocyte count, ×109/L	1.93 (1.54, 2.38)	1.85 (1.23, 2.21)	0.047*
Monocyte count, ×109/L	0.46 (0.38, 0.53)	0.44 (0.33, 0.58)	0.619
Neutrophil count, ×109/L	3.13 (2.50, 3.90)	3.16 (2.54, 4.05)	0.373
Platelet count, ×109/L	188.28±50.19	191.09±65.59	0.713
NLR	1.61 (1.27, 2.12)	1.85 (1.42, 2.49)	0.011*
PLR	98.52 (76.19, 118.17)	101.41 (80.76, 135.57)	0.112
LMR	4.21 (3.44, 5.32)	4.10 (2.98, 5.19)	0.172
hs-CRP, mg/L	1.06 (0.65, 1.86)	1.16 (0.76, 3.48)	0.038*
Albumin, g/L	42.90±3.52	42.44±3.66	0.354
PT	11.70 (11.00, 12.70)	12.40 (11.68, 14.10)	0.000***
APTT	29.35 (25.83, 34.28)	30.25 (26.83, 35.45)	0.479
INR	1.02 (0.95, 1.11)	1.08 (1.02, 1.23)	0.001**
LVEDD, mm	49 (46, 52)	51 (47, 53)	0.023*
LVESD, mm	32 (30, 35)	34 (31, 36)	0.027*
LAD, mm	41.58±5.88	44.79±5.71	0.000***
LVEF, %	0.63 (0.58, 0.67)	0.61 (0.57, 0.64)	0.036*

APTT – activated partial thromboplastin time; HDL-C – high-density lipoprotein cholesterol; INR – international prothrombin time standardized ratio; LDL-C – low-density lipoprotein cholesterin; LMR – lymphocyte-to-monocyte ratio; LAD – left atrial diameter; LVEDD – left ventricular end-diastolic dimension; LVESD – left ventricular end-systolic dimension; LVEF – left ventricular ejection fraction; PLR – platelet-to-lymphocyte ratio; PT – prothrombin time; Scr – serum creatinine; TC – total cholesterol; TG – triglyceride; UA – uric acid;

^*P<0.05,

^**P<0.01,

^***P<0.001.